B-cell proliferation characteristics and monitoring significance under the modified reduced-dose rituximab regimen for NMOSD: A real-world case series study

医学 美罗华 CD19 养生 视神经脊髓炎 多发性硬化 B细胞 内科学 扩大残疾状况量表 流式细胞术 免疫学 胃肠病学 抗体
作者
Shugang Cao,Xiaoyuan Wang,Xiaopei Ji,Jingluan Tian,Yunfei Zhu,Xin Wang,Yanzheng Gu,Xiaoyu Duan,Xinyi Xiao,Qi Fang,Xueguang Zhang,Qun Xue
出处
期刊:Multiple sclerosis and related disorders [Elsevier BV]
卷期号:70: 104524-104524 被引量:4
标识
DOI:10.1016/j.msard.2023.104524
摘要

To explore the B-cell proliferation characteristics and monitoring significance under the modified reduced-dose rituximab (mRTX) regimen for neuromyelitis optica spectrum disorder (NMOSD).NMOSD patients treated with mRTX were recruited, and the percentages of total CD19+ B cells and CD27+ memory B cells were dynamically detected by flow cytometry. The annualized relapse rate (ARR) and expanded disability status scale (EDSS) scores were compared before and after mRTX treatment, and the differences in B-cell values were compared between groups.A total of 34 patients with NMOSD were ultimately enrolled. The EDSS score decreased from 2.5 (1.5, 3.0) to 1.3 (1.0, 2.0), and the ARR decreased from 1.0 (0, 2.0) to 0 (0, 0) (p < 0.001). Relapses occurred in 6 patients, with total CD19+ B-cell percentages of 3.25% (2.7%, 3.7%) and CD27+ memory B-cell percentages of 0.3% (0.2%, 0.3%) at initial relapse. Twenty-eight patients (82.4%) remained relapse-free with 84 doses of mRTX. Before 56 repeated doses, the total CD19+ B cells and CD27+ memory B cells were 4.00% (3.14%, 5.32%) and 0.26% (0.17%, 0.40%), respectively. The mean dosing interval was 9.2 months. Both total CD19+ B cells and CD27+ memory B cells proliferated over time after mRTX use, with significantly faster proliferation rates in the later stages. In 28 relapse-free patients, the mean time to reach 1% for total CD19+ B cells was 210 days, and the mean time to reach 3% was 240 days, with the mean interval from 1% to 3% of 65 days. Twenty-five relapse-free patients had no significant differences in maximum, minimum, and mean B-cell values compared to those of 6 patients with relapse.The high rate of B-cell proliferation under the mRTX regimen indicates that closer dynamic B-cell monitoring is required to guide repeated mRTX dosing. Sustained depletion of total CD19+ B cells targeting < 3% of lymphocytes may be feasible, enabling extended dosing intervals.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
罗擎发布了新的文献求助10
刚刚
彩色的依琴完成签到,获得积分10
刚刚
正经阳完成签到,获得积分10
刚刚
Jade0259完成签到 ,获得积分10
刚刚
飘逸山兰完成签到,获得积分10
1秒前
赵振辉发布了新的文献求助10
1秒前
1秒前
萱瑄爸爸完成签到,获得积分10
1秒前
风风完成签到,获得积分10
2秒前
bai完成签到,获得积分10
2秒前
wx发布了新的文献求助10
2秒前
小羊发布了新的文献求助10
3秒前
赵念婉完成签到,获得积分10
3秒前
wangjianwei完成签到 ,获得积分10
3秒前
江你一军完成签到,获得积分10
3秒前
fang完成签到,获得积分10
4秒前
小小鱼儿完成签到,获得积分10
5秒前
hh完成签到,获得积分10
5秒前
qearl完成签到,获得积分10
5秒前
yyyyyy完成签到,获得积分10
5秒前
壮观的灵凡完成签到 ,获得积分10
5秒前
sunshine完成签到,获得积分10
5秒前
栗子发布了新的文献求助10
5秒前
YY19891219完成签到,获得积分10
6秒前
凶狠的半山完成签到,获得积分10
6秒前
wyd985完成签到,获得积分10
7秒前
7秒前
落后若山发布了新的文献求助10
7秒前
Mia233完成签到 ,获得积分10
7秒前
武科大完成签到,获得积分10
8秒前
豚骨大王完成签到,获得积分10
8秒前
殷勤的书包完成签到,获得积分10
8秒前
雍不斜完成签到,获得积分10
9秒前
橙酒完成签到,获得积分10
9秒前
正经宁完成签到,获得积分10
10秒前
爱逛动物园完成签到,获得积分10
10秒前
bjw111完成签到,获得积分10
10秒前
Cat4pig完成签到 ,获得积分10
10秒前
上上签完成签到,获得积分10
11秒前
中级中级完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152174
求助须知:如何正确求助?哪些是违规求助? 9548914
关于积分的说明 21688336
捐赠科研通 7740386
什么是DOI,文献DOI怎么找? 3425136
关于科研通互助平台的介绍 2550324
邀请新用户注册赠送积分活动 2468584